Latest Content

How Bispecific Antibodies Work and What Patients Can Expect

August 26th 2024, 9:00pm

By Brielle Benyon

Article

Bispecific antibodies connect the immune system with cancer cells. They offer an efficacious treatment option, but there are side effects.

Focusing Energy on Cancer-Related Fatigue

August 26th 2024, 7:00pm

By Ashley Chan

Article

Fatigue is a common side effect that may linger for years following cancer treatment. Experts and survivors talk about ways to help find a balance between life and fatigue.

8 Things to Do While in the Hospital for Cancer Treatment

August 26th 2024, 5:00pm

By Mary Sansone

Article

While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.

FDA Fast Tracks BGB-16673 for CLL, SLL

August 26th 2024, 3:00pm

By Brielle Benyon

Article

The FDA granted a fast track designation to BGB-16673, a novel drug used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma.

A Cancer Nurse Who Is Here to Serve

August 26th 2024, 1:00pm

By Madison Newman

Article

An oncology nurse who is a cancer survivor herself fiercely advocates for all her patients.

Monjuvi May Slow Follicular Lymphoma Progression

August 25th 2024, 5:00pm

By Alex Biese

Article

Monjuvi, Revlimid and Rituxan improved progression-free survival among adults with relapsed or refractory follicular lymphoma, topline research showed.

Upfront Therapy May Decrease Need for Rectal Cancer Surgery

August 24th 2024, 6:00pm

By Brielle Benyon

Article

Chemotherapy and radiotherapy may be efficacious enough for certain patients with advanced rectal cancer to avoid surgery, research showed.

My Tumors: A Poem Inspired By Stevenson’s ‘My Shadow’

August 24th 2024, 2:00pm

By Richard Strickland

Article

I wrote a poem similar to Robert Louis Stevenson’s “My Shadow” about my cancer diagnosis.

‘No Such Thing as a Good Cancer’: Explaining the Big CLL Misconception

August 23rd 2024, 7:00pm

By Alex Biese

Video

One expert explained why chronic lymphocytic leukemia is erroneously considered a ‘good cancer.’

Resources Available to Patients With CLL

August 23rd 2024, 7:00pm

By Alex Biese

Video

From social work to cardio-oncology, there is a wide array of resources potentially available to patients, as one expert explained.

What Patients with CLL Need to Know About Clinical Trials

August 23rd 2024, 7:00pm

By Alex Biese

Video

One expert explains why most of the time clinical trial enrollment is ‘the correct answer’ for patients.

With CLL ‘Cancer Gets Smart, And We Have to Evolve with the Cancer’

August 23rd 2024, 7:00pm

By Alex Biese

Video

There have been major treatment advancements for CLL in the last decade, with future generations of drugs on the horizon.

‘Fighting Cancer’: My Thoughts on the Phrase

August 23rd 2024, 5:00pm

By Karen Cohn

Article

The militaristic terminology of “fighting a disease” does not sit well with me. After being diagnosed, I wasn’t fighting. I was reacting.

Unmet Needs and Challenges in Metastatic Uveal Melanoma

August 23rd 2024, 4:10pm

By Nathan L. Scott, M.D.

Video

Experts discuss unmet needs and challenges faced by patients with uveal melanoma. This program was made possible with support from Immunocore.

Safety and Efficacy of Tebentafusp

August 23rd 2024, 4:05pm

By Nathan L. Scott, M.D.

Video

Nathan L. Scott, M.D., discusses the safety and efficacy of tebentafusp. This program was made possible with support from Immunocore.